152 related articles for article (PubMed ID: 27556512)
21. The Hippo Signaling Pathway Regulates Ovarian Function via the Proliferation of Ovarian Germline Stem Cells.
Ye H; Li X; Zheng T; Hu C; Pan Z; Huang J; Li J; Li W; Zheng Y
Cell Physiol Biochem; 2017; 41(3):1051-1062. PubMed ID: 28245464
[TBL] [Abstract][Full Text] [Related]
22. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
Guo C; Wang X; Liang L
Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
[TBL] [Abstract][Full Text] [Related]
23. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Wu DW; Wang YC; Wang L; Chen CY; Lee H
Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
[No Abstract] [Full Text] [Related]
24. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
25. Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1.
Hwang SK; Piao L; Lim HT; Minai-Tehrani A; Yu KN; Ha YC; Chae CH; Lee KH; Beck GR; Park J; Cho MH
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824095
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
27. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P
Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989
[TBL] [Abstract][Full Text] [Related]
28. Expression of YAP1 in aggressive thyroid cancer.
Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
[No Abstract] [Full Text] [Related]
29. Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
Li P; Sun D; Li X; He Y; Li W; Zhao J; Wang Y; Wang H; Xin Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1765-73. PubMed ID: 27325246
[TBL] [Abstract][Full Text] [Related]
30. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanisms of Leucine Zipper EF-Hand Containing Transmembrane Protein-1 Function in Health and Disease.
Lin QT; Stathopulos PB
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642051
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
34. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
35. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
Lin C; Xu X
Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
[TBL] [Abstract][Full Text] [Related]
36. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
37. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
38. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.
Huang Y; Zhang K; Li Y; Dai Y; Zhao H
Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895
[TBL] [Abstract][Full Text] [Related]
39. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.
Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838
[TBL] [Abstract][Full Text] [Related]
40. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
